Varicella
📧 Sign up to get email alerts when something new happens for Varicella.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-01-30Clinical Trial Update: Comparative Study of Immunogenicity and Safety of a 2-dose Regimen of ProQuad® Manufactured With rHA (V221-038) [Phase 3]
A Phase 3 comparative study evaluating immunogenicity and safety of a two-dose Regimen of ProQuad manufactured with rHA (V221-038) for measl…
-
CLINICAL_TRIALS trial_result · 2017-11-08Clinical Trial Update: Study of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children Previously Immunized With JE-CV [Phase 3]
Phase 3 trial update for JE-CV in children previously immunized with JE-CV; study completed and results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-10-26Clinical Trial Update: A Blind, Randomized and Controlled Study of Live Attenuated Varicella Vaccines [Phase 3]
A blind, randomized, controlled Phase 3 trial of a live attenuated varicella vaccine developed by Sinovac Dalian Vaccine Technology Co., Ltd…
-
CLINICAL_TRIALS trial_result · 2017-10-26Clinical Trial Update: A Safety Study of Live Attenuated Varicella Vaccines in Healthy Adults, Adolescents and Children [Phase 1]
Phase 1 safety study of live attenuated varicella vaccines in healthy adults, adolescents, and children has been completed.
-
CLINICAL_TRIALS trial_result · 2017-10-17Clinical Trial Update: Safety Study of ProQuad® rHA in Infants (V221-037) [Phase 3]
Phase 3 safety study of ProQuad rHA in infants completed; results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-10-11Clinical Trial Update: A Safety and Immune Study of 2 Types of GlaxoSmithKline's Varicella Vaccines Given as a 2-doses Course to Healthy Children 12-23 Months of Age. [Phase 3]
Phase 3 clinical trial evaluating two-dose regimens of GlaxoSmithKline varicella vaccines in healthy children aged 12-23 months; completed w…
-
CLINICAL_TRIALS trial_result · 2017-10-09Clinical Trial Update: Immunogenicity & Safety Study of GSK Biologicals' 208136 Vaccine Formulated With New Measles and Rubella Working Seeds [Phase 2]
Phase 2 immunogenicity and safety study of GSK's 208136 vaccine formulated with new seed strains for measles and rubella; results posted aft…
-
CLINICAL_TRIALS trial_result · 2017-09-25Clinical Trial Update: Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTM [Phase 3]
Phase 3 trial comparing GSK's MMRV vaccine to Priorix; the study is completed and results were posted on 2017-09-25.
-
FDA approval · 2017-08-16FDA Approved: ACYCLOVIR — Original Application (Carlsbad Technology, Inc.)
FDA approves a generic acyclovir product under an Original Application (ANDA) from Carlsbad Technology, Inc.
-
CLINICAL_TRIALS trial_result · 2017-08-04Clinical Trial Update: Tzanck Smear With Methylene Blue Stain for Herpes [Phase 3]
A Phase 3 clinical trial evaluating Tzanck smear with methylene blue stain for herpes diagnosis is currently in unknown status.
-
FDA approval · 2017-07-31FDA Approved: ACYCLOVIR — Original Application (Northstar Rx LLC)
FDA approved Northstar Rx LLC's acyclovir as a generic under an original ANDA, authorizing its sale as a generic acyclovir product. The appr…
-
CLINICAL_TRIALS trial_result · 2017-07-28Clinical Trial Update: Varicella-related Hospitalizations in Turkey
A completed clinical trial sponsored by Eskisehir Osmangazi University in Turkey studied varicella (chickenpox) hospitalizations. The trial …
-
CLINICAL_TRIALS trial_result · 2017-07-19Clinical Trial Update: Cytokine Production and Immunity to Varicella Zoster Virus (VZV) in Elderly Recipients of Zoster Vaccine
An update on cytokine production and immune responses to Varicella Zoster Virus in elderly recipients of the zoster vaccine; the trial statu…
-
CLINICAL_TRIALS trial_result · 2017-07-06Clinical Trial Update: Immunogenicity and Safety of GSK Biologicals' Live Attenuated Varicella Vaccine (VARILRIXTM). [Phase 2]
A Phase 2 trial update on the immunogenicity and safety of GlaxoSmithKline's live attenuated varicella vaccine VARILRIX, with completed stat…
-
CLINICAL_TRIALS trial_result · 2017-06-28Clinical Trial Update: Study of Two Formulations of GSK Biologicals' Varicella Vaccine [Phase 2]
A Phase 2 trial comparing two formulations of GlaxoSmithKline's varicella vaccine has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2017-04-27Clinical Trial Update: Dose-escalation Phase 1 to Evaluate the Safety and Efficacy of MG1111 in Healthy Adults [Phase 1]
A phase 1 dose-escalation study evaluated the safety and potential efficacy of MG1111 in healthy adults; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2017-04-24Clinical Trial Update: Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136 [Phase 3]
Phase 3 immunogenicity and safety study of GlaxoSmithKline's combined measles-mumps-rubella-varicella vaccine has completed, with results po…
-
CLINICAL_TRIALS trial_result · 2017-04-20Clinical Trial Update: Safety Study of NBP608 in Healthy Adult Volunteers [Phase 1]
Phase 1 safety study of NBP608 in healthy adult volunteers has completed; the trial assesses safety and tolerability in contexts related to …
-
CLINICAL_TRIALS trial_result · 2017-04-14Clinical Trial Update: The Evaluation of Immunogenicity and Safety of NBP608 in Healthy Children 12 Months to 12 Years of Age [Phase 2]
Phase 2 trial update evaluating the immunogenicity and safety of NBP608 in healthy children aged 12 months to 12 years for Varicella has bee…
-
CLINICAL_TRIALS trial_result · 2017-03-15Clinical Trial Update: Safety, Tolerability, and Immunogenicity of an Investigational Vaccine With Recombinant Human Albumin (rHA) in Children 12 to 18 Months of Age (V205C-009)(COMPLETED) [Phase 2]
Phase 2 trial results assessing the safety, tolerability, and immunogenicity of an investigational recombinant human albumin (rHA)–based vac…
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: Safety Study of a Refrigerator-stable Formulation of VARIVAX® [Phase 4]
The document reports the completion of a Phase 4 safety study of a refrigerator-stable formulation of VARIVAX (varicella vaccine) sponsored …
-
CLINICAL_TRIALS trial_result · 2017-02-16Clinical Trial Update: Evaluation of the Safety of Varivax® in Pediatric Renal Transplant Recipients [Phase 1]
This Phase 1 study evaluated the safety of Varivax in pediatric renal transplant recipients and was terminated.
-
CLINICAL_TRIALS trial_result · 2017-01-11Clinical Trial Update: Immune Response to Varicella Vaccination in Children With Atopic Dermatitis
A completed NIAID-sponsored trial evaluated the immune response to the varicella vaccine in children with atopic dermatitis.
-
CLINICAL_TRIALS trial_result · 2017-01-09Clinical Trial Update: Immunogenicity and Safety Study of PriorixTetra™ When Co-administered With Conjugated MenC Vaccine in Healthy Children [Phase 3]
Phase 3 trial evaluating immunogenicity and safety of PriorixTetra when co-administered with a conjugated MenC vaccine in healthy children; …
-
FDA approval · 2016-12-21FDA Approved: ACYCLOVIR — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approves Sun Pharmaceutical’s original generic application for acyclovir (oral). The approval enables the commercial production of a gen…